Month: September 2021

The coronavirus pandemic disrupted many businesses and was a boon to others. One sector that’s been riding high is the pharmaceutical industry. That’s especially true for companies that have brought a Covid-19 vaccine to market. Vaccine developer Novavax (NASDAQ:NVAX) is a perfect example. NVAX stock rose from relative obscurity with a share price of just
0 Comments
Jeff Bezos, owner of Blue Origin, introduces a new lunar landing module called Blue Moon during an event at the Washington Convention Center, May 9, 2019 in Washington, DC. Mark Wilson | Getty Images Twenty-one current and former employees of Jeff Bezos’ Blue Origin claim the space company is a “toxic” workplace, according to an
0 Comments
Nvidia’s (NASDAQ:NVDA) core businesses have been firing on all cylinders, and its move into other profitable verticals has resulted in consistent top-line growth.  The company’s market value has grown at an incredible pace over the past decade. Yet, NVDA stock still has a ton of upside left with new catalysts that will amplify growth in
0 Comments
Plug Power (NASDAQ:PLUG), the hydrogen fuel cell company, was somehow able to raise more than $3.4 billion in two different tranches in January and February 2021. The company sold $1.6 billion of PLUG stock at $29.29 in February to a subsidiary of SK Holdings, the third-largest conglomerate in South Korea. Source: Shutterstock Additionally, it managed
0 Comments
In this article MU LLY NFLX LCID DLTR ASML-NL Check out the companies making headlines before the bell: Micron Technology (MU) – Micron reported adjusted quarterly earnings of $2.42 per share, 9 cents above estimates, with the chip maker’s revenue also topping Street forecasts. However, its current-quarter forecast fell below consensus, due to computer-making customers
0 Comments
Starting in the mid-1990s, the United Nations Climate Change Conference established a formal framework for participating countries to gauge their performance in mitigating environmental impact. An increasingly popular summit given the backdrop of the Kyoto Protocol — an international treaty to reduce greenhouse gas emissions — this year’s gathering will take on greater significance, potentially
0 Comments
Any investment in Ocugen (NASDAQ:OCGN) stock is based on hope. That hope involves the FDA approving the Covid-19 vaccine known as Covaxin.    Source: shutterstock.com/PhotobyTawat Over the last six months or so, the company has repeatedly suggested that such an approval was imminent. On Feb. 2,  Ocugen announced an agreement with the Indian drug maker
0 Comments
Jeff Bezos, left, and Elon Musk Getty Images; Reuters Elon Musk repeated prior criticisms of fellow billionaire space mogul Jeff Bezos, as their respective companies continue to battle in federal court and in front of regulators. “I think I’ve expressed my thoughts on that front – I think he should put more of his energy
0 Comments